Gainers
- Kelly Services, Inc. KELYB shares jumped 118.3% to close at $38.21 on Tuesday. Kelly Services released Q2 earnings last week.
- Pfenex Inc. PFNX shares surged 67.5% to close at $12.83 on Tuesday. Ligand Pharmaceuticals Inc. LGND announced plans to acquire Pfenex for $12 per share in cash.
- Oxbridge Re Holdings Limited OXBR shares gained 56.4% to close at $1.83 after the company swung to a profit in the second quarter.
- Biofrontera AG BFRA surged 53.4% to close at $20.32. On Monday, Biofrontera disclosed subscription price for 1.00 % qualified subordinated mandatory convertible bond 2020/2021.
- Eyenovia, Inc. EYEN climbed 38.2% to close at $5.03. Eyenovia and Arctic Vision reported an exclusive collaboration and license agreement to develop and commercialize MicroPine and MicroLine in Greater China and South Korea.
- Linx S.A. LINX shares rose 34.9% to close at $6.26 after StoneCo Ltd. agreed to combine business with Linx SA.
- Hallmark Financial Services, Inc. HALL surged 27.1% to close at $4.17 after reporting Q2 results.
- Kforce Inc. KFRC shares gained 22.6% to close at $38.95 after the company reported better-than-expected Q2 results and also issued strong Q3 guidance.
- NuZee, Inc. NUZE gained 21.8% to close at $38.77.
- Horizon Global Corporation HZN shares jumped 21.5% to close at $5.60. Horizon Global posted a Q2 loss of $0.64 per share last week.
- Trevi Therapeutics, Inc. TRVI rose 19.8% to close at $5.82. Trevi Therapeutics is expected to report Q2 results on August 13.
- RigNet, Inc. RNET gained 17.7% to close at $3.53. RigNet reported a narrower Q2 loss last week.
- Aemetis, Inc. AMTX climbed 16.5% to close at $2.61 after the company highlighted the launch of Aemetis health products subsidiary.
- American Public Education, Inc. APEI gained 16.5% to close at $36.34 after reporting strong Q2 results.
- MVC Capital, Inc. MVC gained 15.7% to close at $7.87 after the company agreed to merge with Barings BDC, Inc.
- i3 Verticals, Inc. IIIV climbed 15.2% to close at $28.86 following upbeat quarterly results. BTIG upgraded i3 Verticals from Neutral to Buy.
- Liquidity Services, Inc. LQDT climbed 15% to close at $7.12.
- J2 Global, Inc. JCOM gained 14.8% to close at $69.03 after the company reported better-than-expected Q2 results. The company also reinstated FY20 sales guidance.
- Vaxart, Inc. VXRT surged 14.4% to close at $10.75. Vaxart, on Monday, filed for an investigational new drug application for a coronavirus vaccine.
- Nautilus, Inc. NLS rose 14.2% to close at $14.12 after reporting a rise in Q2 sales.
- RCI Hospitality Holdings Inc RICK rose 13.8% to close at $16.55 after the company reported better-than-expected Q3 results.
- U.S. Energy Corp. USEG rose 13.5% to close at $6.64.
- IntriCon Corporation IIN gained 13.3% to close at $12.89 following upbeat Q2 results.
- Pieris Pharmaceuticals, Inc. PIRS jumped 13.3% to close at $3.16. Pieris Pharmaceuticals released upbeat quarterly results on Monday.
- VerifyMe, Inc. VRME shares gained 12.5% to close at $4.50.
- Crexendo, Inc. CXDO surged 12.4% to close at $10.45 after reporting Q2 results.
- Leju Holdings Limited LEJU gained 10.7% to close at $2.90. Leju is expected to release H1 results on August 20.
- Pacific Ethanol, Inc. PEIX rose 8% to close at $3.50 after the Nasdaq notified company that it regained compliance.
- The E.W. Scripps Company SSP rose 7% to close at $12.07. E.W. Scripps released Q2 results last week.
- Super League Gaming, Inc. SLGG gained 5% to close at $3.21. Super League and GreenlightGO joined forces to provide production companies and networks with fully-remote virtual studio solution.
- Yield10 Bioscience, Inc. YTEN gained 5% to close at $6.55 after the company signed a research agreement with GDM to evaluate new yield traits in soybean.
Check out these big penny stock gainers and losers
Losers
- Fulcrum Therapeutics Inc FULC shares tumbled 48% to close at $8.90 on Tuesday after the company posted a Q2 loss of $0.66 per share and announced interim analysis data from its ReDUX4 trial in facioscapulohumeral muscular dystrophy.
- Mesoblast limited MESO dropped 35% to close at $11.33. The company has an FDA Advisory Committee meeting on August 13th to review data supporting its Biologics License Application for approval of RYONCIL for children.
- Fennec Pharmaceuticals Inc FENC fell 34.5% to close at $6.66 after the company announced it has received a response from the FDA for PEDMARK NDA indicating identified deficiencies with the facility of the drug product manufacturer, which require resolution prior to PEDMARK approval.
- Sunworks, Inc. SUNW fell 32.2% to close at $0.8403 after the company reported a Q2 loss. The Peck Co. also announced plans to buy Sunworks in a stock deal.
- LightInTheBox Holding Co., Ltd. LITB shares tumbled 26.6% to close at $2.40 on Tuesday after jumping more than 18% on Monday.
- Pixelworks, Inc. PXLW dropped 25.6% to close at $2.54 after reporting a Q2 loss of $0.10 per share.
- Omeros Corporation OMER dropped 25.5% to close at $15.89 after the company reported a wider Q2 loss and announced a $125 million common stock offering. Omeros shares jumped over 50% on Monday after the company reported recovery and survival of all patients in a study evaluating Narsoplimab for the treatment of Covid-19-associated Acute Respiratory Distress Syndrome.
- iBio, Inc. IBIO fell 25.2% to close at $2.76. On Monday, IBio provided an update on its Covid-19 vaccine program.
- Sorrento Therapeutics, Inc. SRNE fell 25.1% to close at $14.09 after surging over 30% on Monday.
- Ideanomics Inc IDEX fell 23.6% to close at $1.36 after the company reported a drop in Q2 EPS and sales.
- PDS Biotechnology Corporation PDSB dropped 23.5% to close at $3.00 after the company priced its 6 million share common stock offering $2.75 per share.
- Inovio Pharmaceuticals, Inc. INO declined 23% to close at $14.62 after the company reported downbeat results for its second quarter on Monday. The company also expects its COVID-19 vaccine to enter mid-to-late stage human trials in September.
- GreenSky, Inc. GSKY declined 22.9% to close at $4.88 after the company reported Q2 results.
- SCWorx Corp. WORX fell 22.3% to close at $2.41. SCWorx resumed trading on the Nasdaq on Monday.
- Catalyst Pharmaceuticals Inc CPRX declined 21.7% to close at $3.34 after the company reported Q2 earnings results.
- Universal Security Instruments, Inc. UUU dipped 18.5% to close at $1.85. Universal Security Instruments posted a Q1 loss of $1.51 per share.
- Navidea Biopharmaceuticals, Inc. NAVB dropped 18.5% to close at $2.82. On Monday, Navidea Biopharmaceuticals signed a binding framework for commercialization partnership with Jubilant Radiopharma.
- OpGen, Inc. OPGN dipped 18.5% to close at $2.56. OpGen’s subsidiary highlighted publication of study that 'demonstrates feasibility of CLIA-compliant next generation sequencing workflow for identification of bacterial pathogens and antibiotic resistance markers.’
- Hycroft Mining Holding Corporation HYMC fell 18.4% to close at $10.21.
- Ontrak, Inc. OTRK fell 18.2% to close at $48.55. Ontrak reported Q2 results last week.
- Document Security Systems, Inc. DSS fell 17.8% to close at $8.60. DSS reported shareholder approval for acquisition of Impact Biomedical.
- Actinium Pharmaceuticals, Inc. ATNM fell 17.4% to close at $9.66. Actinium Pharmaceuticals reported a 1-for-30 reverse stock split.
- FreightCar America, Inc. RAIL dropped 17.2% to close at $1.78 following Q2 results.
- CymaBay Therapeutics Inc CBAY fell 17.1% to close at $5.72 after the company issued Q2 earnings results. It also noted it stopped its review of strategic options and plans to focus on reinstating the clinical development program for seladelpar in PBC.
- Jumia Technologies AG JMIA shares declined 17.1% to close at $16.37.
- Akers Biosciences, Inc. AKER dropped 16.8% to close at $5.44 after the company announced a 1.207 million share common stock offering at $5.67 per share.
- Healthcare Services Group, Inc. HCSG fell 16.8% to close at $22.91.
- Adverum Biotechnologies Inc ADVM fell 16.6% to close at $15.59 after the company announced interim data from Cohorts 1-4 of the OPTIC Phase 1 clinical trial of ADVM-022 intravitreal inject gene therapy.
- Arcturus Therapeutics Holdings Inc. ARCT dropped 16.4% to close at $49.25 after the company reported Q2 results and said it has initiated dosing of its coronavirus STARR mRNA vaccine candidate, LUNAR-COV19 in Phase 1/2 study.
- Novavax, Inc. NVAX fell 16.3% to close at $149.48. The company reported worse-than-expected Q2 sales results on Monday.
- NantKwest, Inc. NK dipped 16.2% to close at $9.45. NantKWest shares surged on Monday after an ImmunityBio study showed positive T Cell and antibody immune responses to its Covid-19 vaccine candidate.
- ANGI Homeservices Inc ANGI fell 16.1% to close at $13.00 in sympathy with its parent company, IAC, after it released weak Q2 earnings results.
- CleanSpark, Inc. CLSK dropped 15.3% to close at $10.33.
- ADiTx Therapeutics, Inc. ADTX fell 15.3% to close at $5.03.
- RumbleON, Inc. RMBL shares declined 15.2% to close at $21.30.
- Prevail Therapeutics Inc. PRVL dropped 14.7% to close at $13.55 after the company reported worse-than-expected Q2 earnings.
- Tilray Inc TLRY fell 13.1% to close at $6.93 after the company reported downbeat Q2 results.
- Trevena, Inc. TRVN fell 12.5% to close at $2.74. Trevena shares jumped around 32% on Monday after the company announced the FDA has approved its OLINVYK injection.
- GTT Communications, Inc. GTT dropped 11.6% to close at $4.96. Raymond James downgraded GTT Communications from Outperform to Underperform.
- Naked Brand Group Limited NAKD fell 11.5% to close at $0.3718 after the company filed for shelf of up to 57.4 million ordinary shares by selling stockholders.
- The Peck Company Holdings, Inc. PECK dropped 10.5% to close at $4.10 after the company posted a Q2 loss and announced plans to buy Sunworks in a stock deal.
- Precigen, Inc. PGEN fell 10.2% to close at $4.60 following wider-than-expected quarterly loss.
- ZoomInfo Technologies Inc ZI fell 9.7% to close at $39.01 despite reporting better-than-expected Q2 results.
- Nio Inc – ADR NIO fell 8.6% to close at $12.99 after the company reported Q2 results. The company also issued Q3 sales guidance above analyst estimates and announced it expects Q3 vehicle deliveries to increase 129.2%-139.6% year-over-year.
- IAC/Interactivecorp IAC fell 7.9% to close at $120.97 after the company reported a loss during the second quarter.
- Strata Skin Sciences SSKN fell 6.2% to close at $1.22 after the company reported Q2 results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasBiotechnologyHealth CareInformation TechnologyInternet Software & ServicesMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in